<JPM's New 'High-Conviction' Stock Picks in Emerging Markets (Table)>
JPMorgan's High-Conviction Stocks: JPMorgan has identified several "High-Conviction" stocks in emerging markets, all rated as Overweight, including Hong Kong-listed BABA-W, PING AN, and ZIJIN MINING.
Stock Performance and Short Selling: The report highlights the short selling data for these stocks, with BABA-W showing a short selling ratio of 17.737%, PING AN at 30.252%, and ZIJIN MINING at 30.161%.
Additional Stock Picks: Other notable stocks listed in different regions include TSMC in Taiwan, Samsung Electronics in South Korea, and State Bank of India in India, among others.
Market Reactions: Morgan Stanley has maintained TENCENT as a top pick, suggesting that the market may be overreacting to potential negative impacts from VAT regulation.
Trade with 70% Backtested Accuracy
Analyst Views on 02318
About the author
Citi's Ratings and Target Prices for Chinese Insurers (Table)
Stock Performance: Several insurance stocks in Hong Kong showed positive movements, with CHINA LIFE increasing by 1.935% and PICC GROUP by 2.744%.
Investment Ratings: Most stocks received a "Buy" rating, including CHINA LIFE, CPIC, and PICC GROUP, while CHINA TAIPING and NCI were rated as "Neutral".
Short Selling Data: Short selling activity varied, with PING AN having the highest short selling amount at $177.33M and a ratio of 22.445%.
Target Price Adjustments: Analysts have adjusted target prices for several stocks, with CHINA LIFE's target raised to HKD40 and PICC P&C's lowered to HKD20.5.
Citi Reports: Upcoming Results Season for Chinese Insurers; China Life Anticipated to Top NBV Growth
Earnings Announcement Period: The earnings announcement period for Hong Kong/China insurers for FY2025 will start on March 19, led by AIA, PRU, and ZA ONLINE.
Growth Expectations: Citi Research anticipates strong growth in new business value for Chinese life insurers, with China Life, Ping An, and CPIC expected to lead with growth rates of 38%, 32%, and 28%, respectively.
Earnings Forecast: The broker predicts solid earnings growth for FY2025, with significant increases expected for China Taiping, China Life, and NCI, among others.
Short Selling Data: The report includes short selling data for various insurers, indicating varying levels of short selling activity and ratios across different companies.
Citi Places CPIC on 90-Day Negative Watch, Anticipates FY25 Performance to Fall Behind Competitors
Citi's Negative Catalyst Watch on CPIC: Citi has initiated a 90-day negative catalyst watch on CPIC (02601.HK), predicting that its FY25 results will underperform compared to peers, with a projected 28% growth in new life insurance business.
Comparative Performance Expectations: The anticipated combined operating ratio for CPIC in FY25 is 98.0%, which is less favorable than major competitors like PICC GROUP and PING AN, whose ratios are forecasted at 97.3% and 97.1%, respectively.
Earnings Growth Projections: CPIC's projected 16% year-over-year earnings increase for FY25 is significantly lower than the expected growth rates of its competitors, such as CHINA TAIPING at 220% and CHINA LIFE at 47%.
Citi's Rating and Target Price: Despite the negative outlook, Citi has rated CPIC as a Buy and set a target price of HKD 44.9.
<Midday Update> HSI Ends Midday at 26,705, Gaining 138 Points; HSTI Reaches 5,367, Up 7 Points; ZIJIN MINING Surges Over 4%; HK & CHINA GAS, CK ASSET, WH GROUP, TIANGONG INT'L, and CONCH VENTURE Achieve New Record Highs
Market Performance: The Hang Seng Index (HSI) rose by 138 points (0.5%) to 26,705, while the Hang Seng Tech Index (HSTI) and the Hang Seng China Enterprises Index (HSCEI) also saw slight gains.
Active Heavyweights: Notable movements included HKEX (+0.9%), PING AN (+0.4%), and TENCENT (+0.2%), while XIAOMI, BABA, and MEITUAN experienced minor declines.
Significant Movers: ZIJIN MINING surged by 4.7%, CHINAHONGQIAO increased by 3.9%, and CNOOC rose by 3.7%, while YUM CHINA fell by 4.6%.
Short Selling Trends: High short selling ratios were observed in several stocks, with YUM CHINA at 47.6% and MEITUAN at 25.8%, indicating significant market speculation.
UOB Kay Hian Supports ALI HEALTH and PA GOODDOCTOR as AI Innovations and National Policies Propel China's Internet Healthcare Industry
Chinese Internet Healthcare Sector Growth: The sector is evolving with increased AI innovation from tech giants and support from national policies, such as Beijing's online consultation pilot program, despite profitability challenges.
Stock Recommendations: UOB Kay Hian maintains a positive outlook on companies like ALI HEALTH and PA GOODDOCTOR, projecting significant revenue growth driven by AI and synergies with major partners.
Top Picks in Healthcare: UOB Kay Hian's top stock picks include BEONE MEDICINES, INNOVENT BIO, and HANSOH PHARMA, highlighting their potential for growth in the Chinese healthcare market.
Investment Ratings: Various companies in the sector have received investment ratings, with several being rated as "Buy," indicating strong confidence in their future performance.
HSI Ends at 27,266, Gaining 83 Points; HSTI Finishes at 5,499, Up 48 Points; XIAOMI Surges Over 4%; TECHTRONIC IND, CHINA RES MIXC, ZTO EXPRESS-W, WH GROUP, CLP HOLDINGS Reach New Peaks; Market Turnover Increases
Market Performance: The Hang Seng Index (HSI) rose by 83 points (0.3%) to close at 27,266, while the Hang Seng Tech Index (HSTI) and the Hang Seng China Enterprises Index (HSCEI) also saw gains, with market turnover reaching $217.22 billion.
Active Heavyweights: Notable movements included Xiaomi (+4.3%), Ping An (-1.3%), Tencent (-0.5%), and Alibaba (-0.2%), with significant short selling activity across these stocks.
HSI & HSCEI Constituents: Key performers included Pop Mart (-5.5%), Techtronic Industries (+4.9%), and BYD Company (+3.5%), with several stocks hitting new highs despite some declines.
HSMI & HSSI Constituents: Synagistics surged by 38.7%, while KB Laminates and CNBM both rose by over 11%, indicating strong performance in certain sectors despite some stocks experiencing declines.
Citi's Ratings and Target Prices for Chinese Insurers (Table)
Stock Performance: Several insurance stocks in Hong Kong showed positive movements, with CHINA LIFE increasing by 1.935% and PICC GROUP by 2.744%.
Investment Ratings: Most stocks received a "Buy" rating, including CHINA LIFE, CPIC, and PICC GROUP, while CHINA TAIPING and NCI were rated as "Neutral".
Short Selling Data: Short selling activity varied, with PING AN having the highest short selling amount at $177.33M and a ratio of 22.445%.
Target Price Adjustments: Analysts have adjusted target prices for several stocks, with CHINA LIFE's target raised to HKD40 and PICC P&C's lowered to HKD20.5.
Citi Reports: Upcoming Results Season for Chinese Insurers; China Life Anticipated to Top NBV Growth
Earnings Announcement Period: The earnings announcement period for Hong Kong/China insurers for FY2025 will start on March 19, led by AIA, PRU, and ZA ONLINE.
Growth Expectations: Citi Research anticipates strong growth in new business value for Chinese life insurers, with China Life, Ping An, and CPIC expected to lead with growth rates of 38%, 32%, and 28%, respectively.
Earnings Forecast: The broker predicts solid earnings growth for FY2025, with significant increases expected for China Taiping, China Life, and NCI, among others.
Short Selling Data: The report includes short selling data for various insurers, indicating varying levels of short selling activity and ratios across different companies.
Citi Places CPIC on 90-Day Negative Watch, Anticipates FY25 Performance to Fall Behind Competitors
Citi's Negative Catalyst Watch on CPIC: Citi has initiated a 90-day negative catalyst watch on CPIC (02601.HK), predicting that its FY25 results will underperform compared to peers, with a projected 28% growth in new life insurance business.
Comparative Performance Expectations: The anticipated combined operating ratio for CPIC in FY25 is 98.0%, which is less favorable than major competitors like PICC GROUP and PING AN, whose ratios are forecasted at 97.3% and 97.1%, respectively.
Earnings Growth Projections: CPIC's projected 16% year-over-year earnings increase for FY25 is significantly lower than the expected growth rates of its competitors, such as CHINA TAIPING at 220% and CHINA LIFE at 47%.
Citi's Rating and Target Price: Despite the negative outlook, Citi has rated CPIC as a Buy and set a target price of HKD 44.9.
<Midday Update> HSI Ends Midday at 26,705, Gaining 138 Points; HSTI Reaches 5,367, Up 7 Points; ZIJIN MINING Surges Over 4%; HK & CHINA GAS, CK ASSET, WH GROUP, TIANGONG INT'L, and CONCH VENTURE Achieve New Record Highs
Market Performance: The Hang Seng Index (HSI) rose by 138 points (0.5%) to 26,705, while the Hang Seng Tech Index (HSTI) and the Hang Seng China Enterprises Index (HSCEI) also saw slight gains.
Active Heavyweights: Notable movements included HKEX (+0.9%), PING AN (+0.4%), and TENCENT (+0.2%), while XIAOMI, BABA, and MEITUAN experienced minor declines.
Significant Movers: ZIJIN MINING surged by 4.7%, CHINAHONGQIAO increased by 3.9%, and CNOOC rose by 3.7%, while YUM CHINA fell by 4.6%.
Short Selling Trends: High short selling ratios were observed in several stocks, with YUM CHINA at 47.6% and MEITUAN at 25.8%, indicating significant market speculation.
UOB Kay Hian Supports ALI HEALTH and PA GOODDOCTOR as AI Innovations and National Policies Propel China's Internet Healthcare Industry
Chinese Internet Healthcare Sector Growth: The sector is evolving with increased AI innovation from tech giants and support from national policies, such as Beijing's online consultation pilot program, despite profitability challenges.
Stock Recommendations: UOB Kay Hian maintains a positive outlook on companies like ALI HEALTH and PA GOODDOCTOR, projecting significant revenue growth driven by AI and synergies with major partners.
Top Picks in Healthcare: UOB Kay Hian's top stock picks include BEONE MEDICINES, INNOVENT BIO, and HANSOH PHARMA, highlighting their potential for growth in the Chinese healthcare market.
Investment Ratings: Various companies in the sector have received investment ratings, with several being rated as "Buy," indicating strong confidence in their future performance.
HSI Ends at 27,266, Gaining 83 Points; HSTI Finishes at 5,499, Up 48 Points; XIAOMI Surges Over 4%; TECHTRONIC IND, CHINA RES MIXC, ZTO EXPRESS-W, WH GROUP, CLP HOLDINGS Reach New Peaks; Market Turnover Increases
Market Performance: The Hang Seng Index (HSI) rose by 83 points (0.3%) to close at 27,266, while the Hang Seng Tech Index (HSTI) and the Hang Seng China Enterprises Index (HSCEI) also saw gains, with market turnover reaching $217.22 billion.
Active Heavyweights: Notable movements included Xiaomi (+4.3%), Ping An (-1.3%), Tencent (-0.5%), and Alibaba (-0.2%), with significant short selling activity across these stocks.
HSI & HSCEI Constituents: Key performers included Pop Mart (-5.5%), Techtronic Industries (+4.9%), and BYD Company (+3.5%), with several stocks hitting new highs despite some declines.
HSMI & HSSI Constituents: Synagistics surged by 38.7%, while KB Laminates and CNBM both rose by over 11%, indicating strong performance in certain sectors despite some stocks experiencing declines.
